Thinking from our team and partners

Type 2 diabetes randomised controlled trial results

People with type 2 diabetes who had a Healum care plan and app saw HbA1c fall 7.4% on average over 6 months. In the control group, it rose 1.8%.

Healum wins NHS contract for patients at risk of CVD

Healum has won an NHS contract to scale its care planning software and patient-facing app for people at risk of cardiovascular disease, across an area that covers 8.5 million patients.

Using digital solutions to aid behaviour change

How Healum worked with Doncaster Bassetlaw Trust to support its ‘Be Well, Feel Good’ tier 2 weight management programme with behaviour change software and a patient app. Of the patients on the programme using the app, 75% lost weight, compared with 15% of those who were not.

Launch of India subsidiary: Healum India Private Ltd

Our India subsidiary, trading as Healum India Pvt Ltd, is now open for business. India is where Healum is launching the first phase of its international expansion, in its mission to provide proactive personalised healthcare for all.

A chat with Jonathan Abraham, CEO of AI-powered healthcare company Healum

Healum’s CEO Jonathan Abraham on why he and Anuj founded the company, how the pandemic changed digital health, and what comes next.

Personalised care planning gives better type 2 diabetes control

In an 18-month trial presented at the Diabetes UK Professional Conference, people who used the Healum app had an average 9.5% reduction in HbA1c, compared with a 2% reduction in a comparable control group.

Treating the blind spot of healthcare inequalities

There are woeful discrepancies in the diagnosis and treatment of type 2 diabetes, especially amongst minority ethnic patients. Healum’s personalised digital care plans aim to reduce them, with positive interim results in South London.

You & Type 2 diabetes project helping to transform patient experiences

A project focused on delivering personalised care for people living with type 2 diabetes has been carried out across South West London. After three months, 73% of people using the app had reductions in HbA1c, against 40% of those who were not.

AI with an ethical conscience

How Healum is harnessing the wisdom of healthcare professionals to deliver intelligent personalised care and support planning for all patients, using machine learning that is ethical, effective and works to overcome algorithmic bias.

How we are helping link workers to support people with long-term conditions

The NHS Long Term Plan promised 1,000 link workers to bridge the gap between people with health conditions and local services. With Sport England and London Sport, we used open data to help link workers at Bromley by Bow Centre signpost people to those services.

The pathway to transformation and acceleration: the vital role of AHSNs

Healum joined CitizenUK and Sweatcoin at the Health Innovation Network’s showcase to demonstrate the vital role that AHSNs play in driving digital change in healthcare. This is how our local AHSN helped us bring personalised care planning to people with type 2 diabetes in south London.

Healum 2.0: the beginning of a new chapter

Today we announce the start of a new chapter, marked by the close of our second round of investment. Healum has now raised over £2m in combined funding, and here we tell you about our journey so far.

Innovate UK awards Healum £536,103 to build AI clinicians can trust

Healum has been awarded a £536,103 Innovate UK grant to develop AI that learns from networks of clinicians, and is opening its Series A investment round.

Pitching at Silicon Roundabout’s #HealthTech evening

Six health tech companies pitched to influencers and entrepreneurs in London. We spoke about supporting people with diabetes and obesity, and about whether the future is predictive or personalised.

Spring 2019: an HSJ shortlisting, social prescribing and a new growth programme

Shortlisted for an HSJ Patient Safety Award, a place on the Business Growth Programme, and the roundtables, forums and workshops that filled our first months of 2019.

Remission at scale: our take on the Diabetes UK Professional Conference 2019

The DiRECT study showed type 2 diabetes remission is possible through weight management. At the Diabetes UK Professional Conference, the question was how to sustain it across a population.

On the AI panel at Health Popup London

Our CEO Jonathan Abraham joined a panel of emerging AI start-ups at Health Popup London, an evening on taking health tech to the USA, funding innovation and the impact of machines on healthcare.

Presenting at the cardiac rehabilitation innovation exchange

Healum CEO Jonathan Abraham presented to clinicians at a London showcase on making the most of digital in cardiac rehabilitation, organised by the British Heart Foundation and London partners.

Autumn 2018: an accelerator, a co-creation day and the conference circuit

Our first months on the DigitalHealth.London Accelerator, a day co-creating with BeeZee Bodies and its participants, and the workshops and conferences in between.

At Genomics England’s 4th Discovery Forum

As a Discovery member of Genomics England, Healum joined its 4th Discovery Forum in London, as the project neared its 100,000th sequenced genome.

Exhibiting at the Deep Learning in Healthcare Summit, London 2018

Two days on deep learning in healthcare, from Google Brain on where expert opinion differs to investors on raising money for health tech, with clinicians and developers at our stand throughout.

Pitching in the Dragons’ Den at AIMed Europe 2018

Healum was one of a few SMEs invited to pitch to an expert panel at AIMed Europe, three days on artificial intelligence and machine learning in healthcare at Shoreditch Town Hall.